glp-1 food industry news today Consumers' Expectations about Drugs Economic Impact on System Players The Impact of GLP-1 on
Description
Rosenlund, J.W
Some patients and healthcare professionals have reported new or worsening depression, anxiety, or suicidal thoughts following initiation of GLP-1 agonist therapy
Maintenance dose: 0.75 to 4.5 mg subcutaneously once a week
Individual variation exists: Some people maintain more of their weight loss than others, particularly those who've established sustainable lifestyle changes during treatment
These considerations can significantly impact your ability to start and continue treatment
doi: 10.1210/jc.2003-030421 32 WynneKParkAJSmallCJPattersonMEllisSMMurphyKGet al
